Skip to main content

Clinical trial 1206 - HNCG

A randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)

Cancers
Organ Cavité buccale et lèvres
Trial status Trial closed for recruitment
Investigator
Trial type
Interventionnal with IMP
Phase Trial phase 2
Academic trial Non
Sponsor EORTC
EudraCT Identifier 2013-000314-38
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01969578
Inclusion criteria metastatic RECIST 1.1
Last update